Skip to content

Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip

CompletedNCT01119885
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to investigate the utility of fentanyl matrix for the treatment of pain due to osteoarthritis (OA) of knee or hip, which was not adequately controlled by non-opioid analgesic (e.g. NSAIDs or COX-II inhibitors) or weak opioids \[tramadol HClacetaminophen, tramadol or codeine (or combinations with acetaminophen/ibuprofen)\].

Study details

Official title
Fentanyl Matrix for the Treatment of Pain Caused by Osteoarthritis of the Knee or Hip: Improvement of Pain and Function: Multicenter, Open-label, Prospective, Observational Study
Interventions
  • Drug: fentanyl matrix
  • Drug: fentanyl matrix
Sponsor
Janssen Korea, Ltd., Korea
Start date
2008-08
Primary completion
2009-01
Sex
All
Age range
from 20 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients who complain of chronic pain caused by osteoarthritis of the knee or hip persisting for 3 months or longer * Patients who can fully observe the overall clinical study requirements including K-WOMAC completion at the investigator's discretion * Patients who complain of severe pain (NRS score = 7) because pain was not treated enough with the previous analgesic * Patients who have never been administered strong opioid analgesics over the last one month Exclusion Criteria: * Patients with a history of the drug or alcohol abuse in the past or now * Childbearing women who are pregnant or likely to be pregnant during the study period and male subjects who are neither infertile nor willing to refrain from sexual relations but whose partner does not conduct an effective contraception (implant, injections, oral contraceptives, intrauterine device, etc.) * Patients who are unable to use a transdermal system due to skin disease * Patients with serious mental disorder * Patients with history of hypersensitivity to opioid analgesics * Patients with history of CO2 retention * Patients who are not eligible for the study participation based on warnings, precautions and contra medications in the package insert of the study drug at the investigator's discretion

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01119885